Cumberland Pharmaceuticals Inc (CPIX.OQ)
CPIX.OQ on NASDAQ Stock Exchange Global Select Market
5.59USD
10:41am EDT
5.59USD
10:41am EDT
Price Change (% chg)
$-0.01 (-0.18%)
$-0.01 (-0.18%)
Prev Close
$5.60
$5.60
Open
$5.67
$5.67
Day's High
$5.84
$5.84
Day's Low
$5.58
$5.58
Volume
6,204
6,204
Avg. Vol
30,971
30,971
52-wk High
$6.71
$6.71
52-wk Low
$4.05
$4.05
About
Cumberland Pharmaceuticals Inc. (Cumberland) is specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. Cumberland is focused on acquiring rights to, developing and commercializing prescription products for the hospital care and gastroenterology markets.... (more)
Overall
| Beta: | 1.45 |
| Market Cap (Mil.): | $103.30 |
| Shares Outstanding (Mil.): | 18.45 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CPIX.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 17.50 | 37.93 | 37.76 |
| EPS (TTM): | 0.32 | -- | -- |
| ROI: | 6.98 | 19.48 | 18.76 |
| ROE: | 7.51 | 20.17 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Takeda Pharmaceutical Company Limited (4502.T) | ¥4,580 | +205.00 |
| Hospira, Inc. (HSP.N) | $41.86 | +1.16 |
| Sucampo Pharmaceuticals, Inc. (SCMP.OQ) | $6.13 | 0.00 |
| Johnson & Johnson (JNJ.N) | $93.87 | +0.37 |
| Novartis AG (NOVN.VX) | CHF66.60 | +0.35 |
| Pfizer Inc. (PFE.N) | $29.18 | -0.05 |
| BASF SE (BASFn.DE) | €67.52 | +0.86 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$58.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

